Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer
Abstract
Aim of investigation. Development of adequate screening and diagnostic algorithms on colorectal cancer detection.
Material and methods. The main group included 204 patients with colorectal cancer (CRC),that has been revealed at screening of 1669 patients by immunochemical fecal occult blood test (FOBT). Control group included 213 CRC patients who have addressed oncologic institutions for intestinal or general complaints independently. Screening program included: immunochromatographic FOBT, blood test for tumor markers — carcinoembryonic antigen (CEA), oncoantigens СА 19-9, СА 242), methylated DNA of septin 9 gene.
Results. Diagnostic efficacy of CRC screening diagnostics by testing of blood levels of CEA, СА 242 and СА 19-9 was 40,4, 50,8 and 51,7% respectively. Epigenetic tests for DNA methylate of SEPT9 gene in blood as screening procedure was characterized by high diagnostic efficacy — 86,5%. At the initial stage of screening diagnostics optimum combination of methods is immunochemical FOBT at 100 ng/ml threshold and assessment of DNA methylate of gene SEPT9 in blood. Diagnostic efficacy of the 1-st stage of screening diagnostics was 90%.
Conclusions. The initial stage of screening diagnostics CRC including immunochemical FOBT tests at threshold of 100 ng/ml, assessment of DNA methylate of SEPT9 gene in blood, provide optimum ratio of sensitivity and specificity and cost efficacy.
About the Authors
O. I. Kit
Federal state-funded institution «Rostov Research Oncology Institute» Ministry of healthcare of Russian Federation
Russian Federation
Russian Federation
Kit Oleg I — MD, PhD, professor, director
344037, Rostov-on-Don, 14-th line street, 63
D. V. Burtsev
Federal state-funded institution of the Rostov area «Regional diagnostic center»
Russian Federation
Russian Federation
A. Yu. Maksimov
Federal state-funded institution «Rostov Research Oncology Institute» Ministry of healthcare of Russian Federation
Russian Federation
Russian Federation
References
1. Воробьев А.В., Протасова А.Э. Общие вопросы скрининга. Практическая онкология 2010; 11(2):53-9.
2. Ганцев Ш.Х. Старинский В.В., Рахматуллина И.Р., Кудряшова Л.Н., Султанова Р.З. Амбулаторнополиклиническая онкология. М.: Гэотар-Медиа, 2012. 448 с.
3. Егоренков В.В., Моисеенко Ф.В. Скрининг рака толстой кишки. Практическая онкология 2010; 11(2):81-7.
4. Имянитов Е.Н. Высокопроизводительные молекулярно генетические методы нового поколения в диагностике и лечении новообразований. Практическая онкология 2011; 12 (4):194-202.
5. Мерабишвили В.М. Злокачественные новообразования в мире, России, Санкт-Петербурге. СПб: Коста, 2011. 290 c.
6. Пальцева Е.М., Самофалова О.Ю., Горбачева Ю.В., Царьков П.В. Молекулярно-биологические маркеры прогрессии рака толстой кишки. Архив патологии 2012; 2:14-8.
7. Сергеева Н.С., Маршутина Н.В. Общие представления о серологических биомаркерах и их месте в онкологии. Практическая онкология 2011; 12 (4):147-54.
8. Солодкий В., Чхиквадзе В., Станоевич У., Дехисси Е. Ранняя диагностика колоректального рака. Врач 2012; 11:20-3.
9. Циммерман Я.С. Колоректальный рак: современное состояние проблемы. Вестник Северо-западного гос. мед. ун-та им. И.И. Мечникова 2012; 1:78-83.
10. Чалык Ю., Рубцов В. Методологические аспекты раннего выявления колоректальных новообразований. Врач 2011; 13:22-4.
11. Akhtar-Zaidi B., Cowper-Sallari R., Corradin O., Saiakhova A. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012; 336(6082):736-9.
Review
For citations:
Kit O.I., Burtsev D.V., Maksimov A.Yu. Diagnostic efficacy of serological and epigenetic methods of screening diagnostics of colorectal cancer. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(6):51-58. (In Russ.)
Views:
93
Email this article 
